Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|October 4, 2024
The challenging inhibition of Aldose Reductase for the treatment of diabetic complications: a 2019-2023 update of the patent literatureBianca Laura Bernardoni, Ilaria D'Agostino, Fabio Scianò, et al.Expert Review of Clinical Pharmacology|February 27, 2024
Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectivesBelén Toledo, Chiara Deiana, Fabio Scianò, et al.Food Chemistry: X|July 23, 2025
Toxic aldehydes in cooking vegetable oils: Generation, toxicity and disposal methodsFabio Scianò, Bianca Laura Bernardoni, Ilaria D'Agostino, et al.Future Medicinal Chemistry|January 25, 2024
Exploring the therapeutic potential of focal adhesion kinase inhibition in overcoming chemoresistance in pancreatic ductal adenocarcinomaFabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.Bioorganic Chemistry|November 18, 2024
Synthesis and biological evaluation of a new class of azole urea compounds as Akt inhibitors with promising anticancer activity in pancreatic cancer modelsCamilla Pecoraro, Fabio Scianò, Daniela Carbone, et al.Marine Drugs|March 27, 2024
Novel [1,3,4]Thiadiazole[3,2-a]pyrimidin-5-ones as Promising Biofilm Dispersal Agents against Relevant Gram-Positive and Gram-Negative PathogensDaniela Carbone, Camilla Pecoraro, Fabio Scianò, et al.Antibiotics (Basel, Switzerland)|June 26, 2026
Imidazo[2,1-b][1,3,4]thiadiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines as Inhibitors of Staphylococcus aureus Biofilm FormationDomenico Schillaci, Fabiana Plescia, Fabio Scianò, et al.Journal of Drug Targeting|July 27, 2024
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profileCamilla Pecoraro, Daniela Carbone, Fabio Scianò, et al.Pageof 1